199803. lajstromszámú szabadalom • Eljárás 1-acil-2,3-dihidro-4(1H)-kinolin-4-oxim-származékok és ezeket tartalmazó gyógyszerkészítmények előállítására

1 HU 199803 B 2 Pl. R1 IR(KBr,cm-‘) NMR(CDCb, ppm) Op. sz. (*C) 70-o 1695,1640, 2,78(2H,t),3,49(3H,s), 102,3-1460,1360 4,31(2H,t), 107,3 h3 co 6,63-7,9 l(7H,m) 71 O 1690,1640, 2,80(2H,t), 121,8-1480,1370 4,20(2H,t), 122,5 F 6,83-7,94(7H,m) 72 1700,1665, 2,87(2H,t), 114,1-1380,1190 4,14(2H,t), 120,3 Br 7,04-7,96(7H,m) 73 o 1700,1660, [DMSO-dó] 176,2-1570,1385 2,88(2H,t),3,99(2H,t), 176,5 02N 7,17-8,22(7H,m) 74 N02 1690,1655, 2,80(2H,t), 179,6-1395,1345 4,07(2H,t), 181,3 Cl 7,07-8,33(6H,m) 75-Ç)-c(cm3 1695,1645, 1,31 (9H,s),2,81 (2H,t), 124,5-1455,1345 4,21(2H, t),6,99-7,95 (7H,m) 127,6 76 1690,1650, 2,3 l(2H,s),2,78(2H,0, 156,1-1370,900 4,09(2H,0,7,02-7,93 160,2 CH3 (6H,m) 77 O 1690,1635, 2,84(2H,0, 141,7-1475,1370 4,25(2H,t), 7,04-7,96(8H,m) 143,6 78 ~Ç}~ ch3 C1 1690,1660, 2,36(3H,s),2,81(2H,0, 157,8-1465,1370 4,09(2H,0 7,02-7,89(6H,m) 158,3 79 co 1695,1660, 2,71(2H,0, 43,2-1460,1360 4,00(2H,0, 47,5 80 TO-O 1680,1640, 1460,1360 7,01-7,91(10H,m) 2,85(2H,0, 4,28(2H,0, 7,00-8,01(10H,m) 134,0-136,5 81 1690,1650, 2,70(2H,0, 129,4-1460,1370 3,96(2H,0, 131,8 i 6,95-7,9 l(7H,m) 82 TO 1690,1640, 2,82(2H,0,3,81(3H,s), 138,6-1460,1355 4,27(2H,t), 140,0 0CH 3 6,95-8,02(7H,m) 83 1690,1635, [DMSO-dö+CDCb] /-N 1470,1360 2,90(2H,0,4,21 (2H,0, 175,8-7,26-7,58(3H,m),7,90-8,09 (2H,m),8,70-8,86(2H,m) 177,8 84 1680,1650, [DMSO-dó] 148,0-N^\ “O 1465,1380 2,86(2H,0,4,20(2H,t), 7,23-7,62(3H,m),7,72-8,12 (3H,m),8,55-8,60( 1 H,m) 149,8 85 TO 1685,1640, [DMSO-dő] 171,7-1490,1400 2,93(2H,0,4,10(2H,0, 7,35-8,01(2H,m),8,07- 8,25(2H,m),8,60-8,82 ( 1 H,m),8,94-9,02(2H,m) 179,2 86 1690,1640, 2,92(2H,t),4,35(2H,0, 149,8-N —. 1480,1375 7,15-7,36(2H,m),8,01 151,0 (lH,d),8,47-8,54(lH,m), N 8,77(lH,d), 9,08-9,12(lH,m) 87 jn 1690,1635, 2,87(2H,t), 94,1-1415,1365 4,36(2H,t), 96,1 6,98-8,03(6H,m) 13

Next

/
Thumbnails
Contents